P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. (Q51678115)
Jump to navigation
Jump to search
scientific article published on 25 November 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. |
scientific article published on 25 November 2014 |
Statements
P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study (English)
Rayid Abdulqawi
Gary Layton
Bruce G McCarthy
25 November 2014